NeuralBase AI Ltd. Announces Completion of Android Version for HeartEase App, iOS Version to Follow

NeuralBase AI Ltd. has reached a significant milestone in the development of its HeartEase app, with the Android version now complete and undergoing final testing. The iOS version is expected to follow shortly, marking a pivotal step towards the app's public release. HeartEase utilizes AI to offer cardiovascular and emotional health insights through intelligent monitoring and personalized wellness recommendations, leveraging NeuralBase AI's proprietary technology.

The completion of the Android version not only brings HeartEase closer to market but also sets the stage for validating the app's technology in real-world conditions. This phase is crucial for gathering user feedback, which will inform further refinements and ensure the app meets the needs of its users across both Android and iOS platforms. The development underscores NeuralBase AI's commitment to enhancing digital health solutions and its broader mission to support preventive health diagnostics.

Vighnesh Dobale, Chief Executive Officer of NeuralBase AI Ltd., highlighted the importance of this milestone, emphasizing the company's focus on ensuring feature parity and performance consistency across platforms. The upcoming release of HeartEase is anticipated to open doors for strategic partnerships with healthcare providers, wellness platforms, and wearable technology companies, further expanding the app's impact and utility.

For more information on NeuralBase AI Ltd. and its initiatives, visit https://www.neuralbase.ai or the Securities & Exchange Commission's EDGAR database at https://www.sec.gov.